Safety assessment of the SGLT2 inhibitors empagliflozin, dapagliflozin and canagliflozin during pregnancy: An ex vivo human placenta perfusion and in vitro studySabrina Kuoni, Ana Paula Simões‐Wüst, Roger Lehmann et al.|Biomedicine & Pharmacotherapy|2024Cited by 15
Simultaneous LC-MS/MS quantification of SGLT2 inhibitors and antipyrine in medium and tissue from human ex vivo placenta perfusionsSabrina Kuoni, R. Steiner, Daniel J. Müller et al.|Journal of Chromatography B|2023Cited by 7
Placental transfer characteristics and functional impact of SGLT2 inhibitors in human experimental modelsSabrina Kuoni, Ana Paula Simões‐Wüst, Alexandra Dolder et al.|Biomedicine & Pharmacotherapy|2026Cited by 0